This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
2Find
3Review
4Get in touch
More info
You can access this
clinical trial
if you have
Stimulant Use & Co-occuring Opioid Use Disorders
and you are
over 18
years old
2
This is a second phase trial assessing
efficacy and side effects of the new treatment.
Show me locations

The purpose

This study will investigate the effects of intranasal administration of oxytocin, a social neuropeptide, on reducing stimulant use, enhancing therapeutic engagement, and susceptibility to stress-induced relapse in Veterans with stimulant use disorders and enrolled in opioid replacement therapy (ORT) program for co-occurring opioid use disorder (OUD).

Provided treatments

  • Drug: Intranasal oxytocin
  • Drug: Intranasal placebo

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT03016598. The sponsor of the trial is VA Office of Research and Development and it is looking for 40 volunteers for the current phase.
Official trial title:
6-week Trial of Oxytocin for Co-occurring Cocaine and Opioid Use Disorders